Brief: Biogen To Buy Alcyone Therapeutics, Expanding Drug Delivery Solutions For Key Products and Pipeline
18/09/2025 12:54
Sept 18 (Reuters) - Biogen Inc BIIB.O: BIOGEN TO ACQUIRE ALCYONE THERAPEUTICS, EXPANDING DRUG DELIVERY SOLUTION PORTFOLIO FOR KEY PRODUCT AND PIPELINE CANDIDATES BIOGEN INC - TO BUY ALCYONE FOR $85M UPFRONT PLUS MILESTONES BIOGEN INC - PLANS SPINRAZA DELIVERY SYSTEM LAUNCH IN 2028 Source text: ID:nGNX8QD0mR Further company coverage: BIIB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ionis Pharmaceuticals
See all newsAnalysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
Brief: Ionis Announces License Agreement With Recordati For Zilganersen In Alexander Disease (Axd) In All Countries Outside The U.S.
Brief: Ionis Pharmaceuticals Says FDA Approved Tryngolza For Severe Hypertriglyceridemia
Brief: FDA Approves Treatment To Reduce Risk Of Acute Pancreatitis In Adults With Severe Hypertriglyceridemia
Brief: Ionis Announces Appointment Of Ludwig Hantson, Ph.D. To Board Of Directors